Work

First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3)

Year: 2024

Type: article

Study design: Case Report

Source: Clinical Nuclear Medicine

DOI: 10.1097/rlu.0000000000005439

Authors: Tilman Speicher, Caroline Burgard, Moritz Bastian, Florian Rosar, Mark Bartholomä, Stephan Maus, Samer Ezziddin

Institution: Saarland University

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404633223

FWCI: 1.326

Cites: 12

Cited by: 5

Related to: 10